To determine the in vivo residence time of the Db-FM adaptor on tumor cells, we injected 50 μg of CD117 Db-FM in NSG mice, engrafted ten days prior with 1 × 105 MOLM14-CD117high GFP+Luc+ cells (Fig. 5C). This evidence concerns the gene KIT and neoplasm.